27th Mar 2020 15:21
Synairgen plc
("Synairgen" or the "Company")
Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 27 March 2020 that Leonard Licht, a private investor, now holds 9,720,000 ordinary shares of 1 pence each in the capital of the Company, representing 8.88% of the Company's issued share capital.
Enquiries:
Synairgen plc | +44 (0) 23 8051 2800 |
Richard Marsden (Chief Executive Officer)John Ward (Finance Director) | |
finnCap - nominated adviser and broker | +44 (0) 20 7220 0500 |
Geoff Nash / Kate Bannatyne / Charlie Beeson (Corporate Finance)Alice Lane / Manasa Patil (ECM) | |
Consilium Strategic Communications - financial media and investor relations adviser | +44 (0) 20 3709 5700 |
Mary-Jane Elliott / Sue Stuart / Olivia Manser |
Related Shares:
Synairgen